Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tavo
Tavo
OncoSec sheds 45% of staff to fund IL-12 drug through Keytruda combo trial
Fierce Biotech
Wed, 10/5/22 - 10:31 am
OncoSec Medical
melanoma
clinical trials
Keytruda
layoffs
Tavo
OncoSec’s defense of weak preliminary Tavo data for PD-1 resistant melanoma can’t stop a rout
Endpoints
Tue, 11/6/18 - 11:52 pm
OncoSec
Merck
Keytruda
Tavo
melanoma